Oxidant/antioxidant status in patients with recurrent aphthous stomatitis

Clinical and Experimental Dermatology

Volumn 28, Issue 6, 2003, Pages 647-650

  Cimen M Y B ^a   Kaya, T I ^a   Eskandari, G ^a   Tursen, U ^a   Ikizoglu, G ^a   Atik, U ^a  

^a MERSIN UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; CATALASE; GLUTATHIONE PEROXIDASE; MALONALDEHYDE; OXIDIZING AGENT; SUPEROXIDE DISMUTASE;

APHTHOUS STOMATITIS; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; ERYTHROCYTE; HEALTH STATUS; HUMAN; HUMAN CELL; INTERMETHOD COMPARISON; OXIDATION; PATIENT SELECTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE;

ADULT; ANTIOXIDANTS; ASCORBIC ACID; CATALASE; ERYTHROCYTES; FEMALE; GLUTATHIONE PEROXIDASE; HUMANS; MALE; MALONDIALDEHYDE; MIDDLE AGED; OXIDANTS; PROSPECTIVE STUDIES; RECURRENCE; SELENIUM; STOMATITIS, APHTHOUS; SUPEROXIDE DISMUTASE;

EID: 0242406990     PISSN: 03076938     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2230.2003.01415.x     Document Type: Article

References (28)

1. Ship JA, Chavez EM, Doerr PA et al. Recurrent aphthous stomatitis. Quintessence Int 2000; 31: 95-112.
2. Nolan A, McIntosh WB, Allam BF et al. Recurrent aphthous ulceration: vitamin B1, B2, and B6 status and response to replacement therapy. J Oral Pathol Med 1991; 20: 389-91.
3. Ruah CB, Stram JR, Chasin WD. Treatment of severe recurrent aphthous stomatitis with colchicine. Arch Otolaryngol Head Neck Surg 1988; 114: 671-5.
4. Eisenbud L, Horowitz I, Kay B et al. Recurrent aphthous stomatitis of the Behçet's type: successful treatment with thalidomide. Oral Surg Oral Med Oral Pathol 1987; 64: 289-92.
5. Pedersen A, Klausen B, Hougen HP et al. Immunomodulation by longovital in patients with recurrent aphthous ulceration. J Oral Pathol 1990; 19: 376-80.
6. Durak I, Canbolat O, Kavutcu M et al. Activities of total, cytoplasmic and mitochondrial superoxide dismutase enzymes in sera and pleural fluids from patients with lung cancer. J Clin Laboratory Anal 1996; 10: 17-20.
7. Paglia DE, Valentine WN. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Laboratory Clin Med 1967; 70: 158-69.
8. Aebi H. Catalase. In: Methods of Enzymatic Analysis (Bergmeyer, HU, ed). New York: Academic Press 1974, 673-7.
9. Van YeTM, Roza AM, Pieper GM et al. Inhibition of intestinal lipid peroxidation does not minimize morphological damage. J Surg Res 1993; 55: 553-8.
10. Özturk HS, Çimen MYB, Çimen ÖB et al. Oxidant/anti-oxidant status of plasma samples from patients with rheumatoid arthritis. Rheumatol Int 1999; 19: 35-7.
11. Greenberg MS, Pinto A. Etiology and management of recurrent aphthous stomatitis. Curr Infect Dis Rep 2003; 5: 194-8.
12. Sistig S, Cekic-Arambasin A, Rabetic S et al. Natural immunity in recurrent aphthous ulceration. J Oral Pathol Med 2001; 30: 275-80.
13. Freysdottir J, Lau S, Fortune F. Gammadelta T cells in Behçet's disease and recurrent aphthous stomatitis. Clin Exp Immunol 1999; 118: 451-7.
14. Healy CM, Carvalho D, Pearson JD et al. Raised anti-endothelial cell autoantibodies (AECA), but not anti-neutrophil cytoplasmic autoantibodies (ANCA), in recurrent oral ulceration: modulation of AECA binding by tumour necrosis factor-alpha (TNF-alpha) and interferon-gamma (IFN-gamma). Clin Exp Immunol 1996; 106: 523-8.
15. Ueta E, Umazume M, Yamamoto T et al. Leukocyte dysfunction in oral mucous membrane diseases. J Oral Pathol Med 1993; 22: 120-5.
16. Mills MP, Mackler BF, Nelms DC et al. Quantitative distribution of inflammatory cells in recurrent aphthous stomatitis. J Dent Res 1980; 59: 562-6.
17. Greenspan JS, Gadol N, Olson JA et al. Antibody-dependent cellular cytotoxicity in recurrent aphthous ulceration. Clin Exp Immunol 1981; 44: 603-10.
18. Dagalis P, Bagg J, Walker DM. Spontaneous migration and chemotactic activity of neutrophil polymorphonuclear leukocytes in recurrent aphthous ulceration. Oral Surg Oral Med Oral Pathol 1987; 64: 298-301.
19. Wray D, Charon J. Polymorphonuclear neutrophil function in recurrent aphthous stomatitis. J Oral Pathol Med 1991; 20: 392-4.
20. Honma T. Electron microscopic observation of infiltrating neutrophils in aphthous ulceration in Behçet's disease. Acta Derm Venereol (Stockh) 1980; 60: 521-4.
21. Healy CM, Thornhill MH. Induction of adhesion molecule expression on blood vessels and keratinocytes in recurrent oral ulceration. J Oral Pathol Med 1999; 28: 5-11.
22. Winrow VR, Winyard PG, Morris CJ, Blake DR. Free radicals in inflammation: second messengers and mediators of tissue destruction. In: Free Radicals in Medicine (Cheeseman, KH, Slater, TF, eds). Edinburgh: Churchill Livingstone 1993, 642-52.
23. Brody L, Powell SR, Collier KP et al. Increased oxidative stress and decreased antioxidant defenses in mucosa of inflammatory bowel disease. Dig Dis Sci 1996; 41: 2078-86.
24. Durak I, Yasa M, Bektas A et al. Mucosal antioxidant defense is not impaired in ulcerative colitis. Hepato-Gastroenterology 2000; 47: 1015-7.
25. Kokcam I, Naziroglu M. Antioxidants and lipid peroxidation status in the blood of patients with psoriasis. Clin Chim Acta 1999; 289: 23-31.
26. Leggott PJ, Robertson PB, Jacob RA et al. Effects of ascorbic acid depletion and supplementation on periodontal health and subgingival microflora in humans. J Dent Res 1991; 70: 1531-6.
27. 7 Veretinskaia AG, Kosorukova N, Ya Kazakova RV. Corrective effect of ascorbic acid on the status of the sympatho-adrenal system in patients with chronic recurrent aphthous stomatitis. Stomatologiia 1983; 62: 20-2.
28. Delilbasi E, Turan B, Yucel E et al. Selenium and Behçet's disease. Biol Trace Elem Res 1991; 28: 21-5.